Oscar Health (NYSE:OSCR) Shares Down 5.1% – Time to Sell?

Oscar Health, Inc. (NYSE:OSCR) was down 5.1% during mid-day trading on Wednesday . The stock traded as low as $14.97 and last traded at $15.1060. Approximately 4,386,682 shares traded hands during mid-day trading, a decline of 50% from the average daily volume of 8,734,308 shares. The stock had previously closed at $15.92.

Wall Street Analysts Forecast Growth

OSCR has been the topic of a number of analyst reports. Wall Street Zen lowered shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, December 6th. Stephens assumed coverage on Oscar Health in a research report on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price for the company. The Goldman Sachs Group initiated coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They set a “neutral” rating and a $17.00 price target for the company. UBS Group upgraded shares of Oscar Health from a “sell” rating to a “neutral” rating and raised their target price for the stock from $12.00 to $17.00 in a report on Friday, January 9th. Finally, Zacks Research upgraded shares of Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. One analyst has rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. Based on data from MarketBeat, Oscar Health presently has a consensus rating of “Reduce” and an average price target of $17.00.

Oscar Health Stock Up 0.0%

The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The business’s fifty day moving average is $15.89 and its two-hundred day moving average is $16.81.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative net margin of 2.16% and a negative return on equity of 21.50%. The firm’s quarterly revenue was up 23.2% on a year-over-year basis. During the same period in the previous year, the company earned ($0.22) earnings per share. Sell-side analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Insider Buying and Selling at Oscar Health

In related news, insider Janet Liang sold 7,338 shares of the firm’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $121,737.42. Following the transaction, the insider owned 172,527 shares of the company’s stock, valued at approximately $2,862,222.93. This trade represents a 4.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Mario Schlosser sold 286,182 shares of the business’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $15.27, for a total transaction of $4,369,999.14. Following the sale, the insider directly owned 501,148 shares of the company’s stock, valued at approximately $7,652,529.96. The trade was a 36.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 483,307 shares of company stock worth $7,635,300 over the last quarter. Company insiders own 24.39% of the company’s stock.

Institutional Trading of Oscar Health

A number of institutional investors have recently bought and sold shares of OSCR. Envestnet Asset Management Inc. raised its stake in Oscar Health by 200.9% in the second quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after buying an additional 20,171 shares in the last quarter. Udine Wealth Management Inc. boosted its stake in Oscar Health by 138.4% during the 3rd quarter. Udine Wealth Management Inc. now owns 146,555 shares of the company’s stock worth $2,774,000 after purchasing an additional 85,083 shares during the period. Matauro LLC acquired a new stake in shares of Oscar Health during the second quarter worth about $1,508,000. Kingswood Wealth Advisors LLC purchased a new position in shares of Oscar Health in the 2nd quarter valued at approximately $576,000. Finally, Lane Generational LLC acquired a new position in shares of Oscar Health in the second quarter valued at approximately $4,800,000. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.